Skip to main content
PMC home page
Annals of Noninvasive Electrocardiology logoLink to Annals of Noninvasive Electrocardiology
. 2006 Oct 27;6(4):333–341. doi: 10.1111/j.1542-474X.2001.tb00127.x

ISHNE Guidelines for Electrocardiographic Evaluation of Drug‐related QT Prolongation and Other Alterations in Ventricular Repolarization: Task Force Summary

A Report of the Task Force of the International Society for Holter and Noninvasive Electrocardiology (ISHNE), Committee on Ventricular Repolarization

Arthur J Moss ✉, Chair Wojciech Zareba, Jesaia Benhorin, Jean‐Philippe Couderc, Harold Kennedy, Emanuela Locati‐Heilbron, Pierre Maison‐Blanche
PMCID: PMC7027691  PMID: 11686915

The content is available as a PDF (898.5 KB).

REFERENCES

  • 1. Wang Q, Curran ME, Splawski I, et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996;12:17–23. [DOI] [PubMed] [Google Scholar]
  • 2. Curran ME, Splawski I, Timothy KW, et al. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995;80:795–803. [DOI] [PubMed] [Google Scholar]
  • 3. Wang Q, Shen J, Splawski I, et al. SCN5A mutations cause an inherited cardiac arrhythmia, long QT syndrome. Cell 1995;80:805–811. [DOI] [PubMed] [Google Scholar]
  • 4. Splawski I, Tristani‐Firouzi M, Lehmann MH, et al. Mutations in the hminK gene cause long QT syndrome and supress Iks function. Nat Genet 1997;17:338–340. [DOI] [PubMed] [Google Scholar]
  • 5. Abbott GW, Sesti F, Splawski I, et al. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 1999;97:175–187. [DOI] [PubMed] [Google Scholar]
  • 6. Monahan BP, Ferguson CL, Killeavy ES, et al. Torsades de pointes occurring in association with terfenadine use. JAMA 1990;264:2788–2790. [PubMed] [Google Scholar]
  • 7. Haverkamp W, Breithardt G, Camm AJ, et al. The potential for QT prolongation and proarrhythmia by non‐antiarrhythmic drugs. Clinical and regulatory implications. Cardiovasc Res 2000;47: 219–233. [DOI] [PubMed] [Google Scholar]
  • 8. Committee for Proprietary Medicinal Products . Points to Consider: The Assessment of the Potential for QT Interval Prolongation by Non‐Cardiovascular Medicinal Products. The European Agency for the Evaluation of Medicinal Products. December, 1997.
  • 9. Mitcheson JS, Chen J, Lin M, et al. A structural basis for drug‐induced long QT syndrome. Proc Natl Acad Sci USA 2000;97:12329–12333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Lau CP, Freeman AR, Fleming SJ, et al. Hysteresis of the ventricular paced QT interval in response to abrupt changes in pacing rate. Cardiovasc Res 1988;22:67–72. [DOI] [PubMed] [Google Scholar]
  • 11. Morganroth J, Silber SS. How to obtain and analyze electrocardiograms in clinical trials: focus on issues in measuring and interpreting changes in the QTc interval duration. Ann Noninvas Electrocardiol 1999;4:425–433. [Google Scholar]
  • 12. Malik M, Camm AJ. Evaluation of drug‐induced QT interval prolongation: Implications for drug approval and labelling. Drug Safety 2001z; 24:323–351. [DOI] [PubMed] [Google Scholar]
  • 13. Moss AJ. Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. Am J Cardiol 1993;72:23B–25B. [DOI] [PubMed] [Google Scholar]
  • 14. Merri M, Benhorin J, Alberti M, et al. Electrocardiographic quantitation of ventricular repolarization. Circulation 1989;80:1301–1308. [DOI] [PubMed] [Google Scholar]
  • 15. Ahnve S. Correction of the QT interval for heart rate: review of different formulas and the use of Bazett's formula in myocardial infarction. Am Heart J 1985;109:568–574. [DOI] [PubMed] [Google Scholar]
  • 16. Sagie A, Larson MG, Goldberg RJ, et al. An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study). Am J Cardiol 1992;70:797–801. [DOI] [PubMed] [Google Scholar]
  • 17. Rautaharju PM, Warren JW, Calhoun HP. Estimation of QT prolongation. J Electrocardiol 1991;23:111–117. [DOI] [PubMed] [Google Scholar]
  • 18. Malik M. Problems of heart rate correction in the assessment of drug‐induced QT interval prolongation. J Cardiovasc Electrophysiol 2001;12:411–420. [DOI] [PubMed] [Google Scholar]
  • 19. Malik M, Färbom P, Batchvarov V, et al. The relationship between QT and RR intervals is highly individual among healthy subjects ‐ Implications for heart rate correction of the QT interval. Heart 2001;in press. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Benhorin J, Merri M, Alberti M, et al. The long QT syndrome: New electrocardiographic diagnostic criteria. Circulation 1990;82:521–527. [DOI] [PubMed] [Google Scholar]
  • 21. Priori AG, Mortara DW, Napolitano C, et al. Evaluation of the spatial aspects of T‐wave complexity in the long QT syndrome. Circulation 1997;96:3006–3012. [DOI] [PubMed] [Google Scholar]
  • 22. Acar B, Yi G, Hnatkova K, Malik M. Spatial, temporal and wavefront direction characteristics of 12‐lead T wave morphology. Med Biol Eng Comput 1999;37:574–584. [DOI] [PubMed] [Google Scholar]
  • 23. Zabel M, Acar B, Klingenheben T, et al. Analysis of 12‐lead T‐wave morphology for risk stratification after myocardial infarction. Circulation 2000;102:1252–1257. [DOI] [PubMed] [Google Scholar]
  • 24. Merri M, Moss AJ, Benhorin J, et al. Relation between ventricular repolarization duration and cardiac cycle length during 24‐hour Holter recordings: Findings in normal patients and patients with long QT syndrome. Circulation 1992;85:1816–1821. [DOI] [PubMed] [Google Scholar]
  • 25. Badilini F, Maison‐Blanche P, Childers R, et al. QT interval analysis on ambulatory electrocardiogram recordings: a selective beat averaging approach. Med Biol Eng Comput 1999;37:71–79. [DOI] [PubMed] [Google Scholar]
  • 26. Zareba W. Dispersion of repolarization: time to move beyond QT dispersion. Ann Noninvas Electrocardiol 2000;5: 373–381. [Google Scholar]
  • 27. Malik M, Batchvarov VN. Measurement, interpretation, and clinical potential of QT dispersion. J Am Coll Cardiol 2000;36:1749–66. [DOI] [PubMed] [Google Scholar]
  • 28. Couderc J‐P, Zareba W, Burattini L, et al. Beat‐to‐beat repolarization variability in LQTS patients with the SCN5A sodium channel gene mutation. PACE 1999;22:1581–1592. [DOI] [PubMed] [Google Scholar]
  • 29. Badilini F, Fayn J, Maison‐Blanche P, et al. Quantitative aspects of ventricular repolarization: relationship between three‐dimensional T wave loop morphology and scalar QT dispersion. Ann Noninvas Electrocardiol 1997: 2:146–157. [Google Scholar]
  • 30. Burattini L, Zareba W, Moss AJ. Correlation method for detection of transient T‐wave alternans in digital Holter ECG recordings. Ann Noninvas Electrocardiol 1999;22:1581–1592. [Google Scholar]
  • 31. Rosenbaum DS, Jackson LE, Smith JM, et al. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med 1994;330:235–241. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Noninvasive Electrocardiology are provided here courtesy of International Society for Holter and Noninvasive Electrocardiology, Inc. and Wiley Periodicals, Inc.

RESOURCES